First-line atezolizumab monotherapy vs. single-agent chemotherapy in patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum-based therapy: Analysis of the IPSOS Asian subpopulation
Authors
C Schulz
Baohui Han (ORCID: https://orcid.org/0009-0002-3777-2621)
Vilma Graupner
Li-Ming Cao (ORCID: https://orcid.org/0000-0001-6633-6613)
H. Zhong
G. Wu
Elen Höglander
Cẩm Phương Phạm
Anh Tuấn Lê
Siow Ming Lee
Stefanie Morris
Nong Yang
Solange Peters
Dingzhi Huang
Kai Wang
Youyou Hu
Barbara Gitlitz
Verena Lam
Jun Zhao
Institutions
Zhejiang International Studies University (CN)
Roche (Switzerland) (CH)
University of Science and Technology of China (CN)
Union Hospital (HK)
University College London Hospitals NHS Foundation Trust (GB)
Peking University (CN)
Cho Ray Hospital (VN)
Centre Hospitalier Universitaire Vaudois (CH)
Tianjin Medical University Cancer Institute and Hospital (CN)
Shanghai Chest Hospital (CN)
University Hospital Regensburg (DE)
Peking University Cancer Hospital (CN)
Second People Hospital of Hunan (CN)
Hunan Cancer Hospital (CN)
Anhui Provincial Hospital (CN)
CRUK Lung Cancer Centre of Excellence (GB)
Bạch Mai Hospital (VN)
University College London (GB)
Huazhong University of Science and Technology (CN)
First-line atezolizumab monotherapy vs. single-agent chemotherapy in patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum-based therapy: Analysis of the IPSOS Asian subpopulation
C Schulz, Baohui Han, Vilma Graupner, Li-Ming Cao et al.
Journal
Chinese Medical Journal
Topics
Lung Cancer Treatments and Mutations
article
First-line atezolizumab monotherapy vs. single-agent chemotherapy in patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum-based therapy: Analysis of the IPSOS Asian subpopulation
C Schulz, Baohui Han, Vilma Graupner, Li-Ming Cao, H. Zhong, G. Wu, Elen Höglander, Cẩm Phương Phạm, Anh Tuấn Lê, Siow Ming Lee, Stefanie Morris, Nong Yang, Solange Peters, Dingzhi Huang, Kai Wang, Youyou Hu, Barbara Gitlitz, Verena Lam, Jun Zhao
article en
Abstract
No abstract available for this paper.
Publication Tag
Chinese Medical Journal
Institutions
Zhejiang International Studies University (CN), Roche (Switzerland) (CH), University of Science and Technology of China (CN), Union Hospital (HK), University College London Hospitals NHS Foundation Trust (GB), Peking University (CN), Cho Ray Hospital (VN), Centre Hospitalier Universitaire Vaudois (CH), Tianjin Medical University Cancer Institute and Hospital (CN), Shanghai Chest Hospital (CN), University Hospital Regensburg (DE), Peking University Cancer Hospital (CN), Second People Hospital of Hunan (CN), Hunan Cancer Hospital (CN), Anhui Provincial Hospital (CN), CRUK Lung Cancer Centre of Excellence (GB), Bạch Mai Hospital (VN), University College London (GB), Huazhong University of Science and Technology (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
First-line atezolizumab monotherapy vs. single-agent chemotherapy in patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum-based therapy: Analysis of the IPSOS Asian subpopulation — C Schulz, Baohui Han, et al. · Chinese Medical Journal (2025) | TGRS Research Map | TGRS